Optimizing electronic health record prompts with behavioral economics to improve prescribing for older adults

优化电子健康记录促进行为经济学改善老年人处方

基本信息

  • 批准号:
    10245079
  • 负责人:
  • 金额:
    $ 70.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-15 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Prescribing of potentially unsafe medications for older adults is extremely common; benzodiazepines, antipsychotics, anticholinergics, and sedative hypnotics are four key drug classes frequently implicated in adverse health consequences for vulnerable older adults, such as confusion or sedation, leading to hospitalizations, falls, and fractures. Fortunately, most of these consequences are preventable. Physicians’ lack of awareness of alternatives, ambiguous practice guidelines, and perceived pressure from patients or caregivers are among the reasons why these drugs are used more than might be optimal. Reducing inappropriate use of these drugs may be achieved through decision support tools for providers that are embedded in electronic health record (EHR) systems. While EHR strategies are widely used to support the informational needs of providers, these tools have demonstrated only modest effectiveness at improving prescribing. The effectiveness of these tools could be enhanced by leveraging principles of behavioral economics and related sciences. In specific, three behavioral economic principles, such as salience effects, social norming, and default bias, have successfully changed behavior in other settings but have had very limited application in EHRs and, more specifically, for prescribing in older adults. To this end, we propose three cluster randomized controlled trials of novel EHR decision support tools that seek to reduce inappropriate prescribing for these drug classes and their associated adverse drug events and health outcomes. This proposal builds on many years of research by our group on interventions to engage providers and patients in clinical-decision making, behavior change, and evaluating novel interventions in real- world delivery systems. The EHR decision support tools will be designed using promising behavioral economic principles such as salience effects, social norming, and default bias. The specific aims of this study are to: (1) design and pilot test multiple EHR decision support tools constructed using behavioral economics principles; (2) rapidly identify the potential effectiveness of numerous EHR tools at reducing inappropriate prescribing using a novel randomized adaptive design; (3) examine whether these most potentially promising EHR tools from Aim 2 reduce inappropriate prescribing and adverse drug events when using a randomized parallel group trial; and (4) evaluate the effectiveness of the EHR tools in a different clinical environment. Using rigorous randomized designs, we have proposed a pragmatic and scalable approach to optimizing and evaluating EHR tools aimed at provider behavior change for prescribing for older adults. We will also be able to rigorously test a large number of EHR tools as well as replicate and validate the effectiveness of the best performing tools in a different healthcare system. The expected overall impact of this innovative proposal is that it will fundamentally advance how behavioral economics can be used to optimize decision support to reduce inappropriate prescribing and ultimately improve patient outcomes.
为老年人开具潜在不安全的药物是极为普遍的。苯二氮卓类药物, 抗精神病药,抗胆碱能和镇静催眠药是经常实施的四个关键药物类别 对脆弱的老年人(例如混乱或镇静)造成的不利健康后果,导致 住院,跌倒和骨折。幸运的是,这些后果大多数是可以预防的。医生的 缺乏对替代方案的认识,模棱两可的实践指南以及患者的感知压力或 护理人员是使用这些药物多于最佳的原因之一。减少 可以通过为提供者的决策支持工具来实现这些药物的不当使用 嵌入电子健康记录(EHR)系统中。 EHR策略被广泛用于支持 提供商的信息需求,这些工具仅证明了改善的适度有效性 处方。通过利用行为原则,可以增强这些工具的有效性 经济学和相关科学。在特定的三种行为经济原则(例如显着效应)中, 社会规范和违约偏见已成功改变了其他环境的行为,但有非常 在EHR中的应用有限,更具体地说是在老年人中处方。 为此,我们提出了新的EHR决策支持工具的三个集群随机对照试验, 寻求减少这些药物类及其相关的不良药物事件的不适当处方,以及 健康结果。这项提案是在我们小组多年来研究干预措施的多年研究的基础上建立的 提供者和患者在临床决策,改变行为以及评估新型干预措施中 世界交付系统。 EHR决策支持工具将使用有希望的行为经济设计 诸如显着效应,社会规范和默认偏见之类的原则。 这项研究的具体目的是:(1)设计和试点测试多重EHR决策支持工具 使用行为经济学原则建造; (2)迅速确定众多的潜在有效性 EHR工具使用新颖的随机自适应设计来减少不适当的处方; (3)检查 这些最有可能来自AIM 2的最有前途的EHR工具减少了不适当的开处方和敌对 使用随机平行组试验时的药物事件; (4)评估EHR工具的有效性 在不同的临床环境中。使用严格的随机设计,我们提出了务实的 优化和评估EHR工具的可扩展方法,旨在规定提供商行为的行为更改 对于老年人。我们还将能够严格测试大量EHR工具以及复制和 验证不同医疗保健系统中最佳性能工具的有效性。总体预期 这项创新提议的影响是,它将从根本上推进如何使用行为经济学 优化决策支持以减少不适当的处方并最终改善患者的结果。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Rationale and design of the Novel Uses of adaptive Designs to Guide provider Engagement in Electronic Health Records (NUDGE-EHR) pragmatic adaptive randomized trial: a trial protocol.
  • DOI:
    10.1186/s13012-020-01078-9
  • 发表时间:
    2021-01-07
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lauffenburger JC;Isaac T;Trippa L;Keller P;Robertson T;Glynn RJ;Sequist TD;Kim DH;Fontanet CP;Castonguay EWB;Haff N;Barlev RA;Mahesri M;Gopalakrishnan C;Choudhry NK
  • 通讯作者:
    Choudhry NK
Designing and conducting adaptive trials to evaluate interventions in health services and implementation research: practical considerations.
设计和进行适应性试验以评估卫生服务干预措施和实施研究:实际考虑。
  • DOI:
    10.1136/bmjmed-2022-000158
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lauffenburger,JulieC;Choudhry,NiteeshK;Russo,Massimiliano;Glynn,RobertJ;Ventz,Steffen;Trippa,Lorenzo
  • 通讯作者:
    Trippa,Lorenzo
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Niteesh K Choudhry其他文献

Niteesh K Choudhry的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Niteesh K Choudhry', 18)}}的其他基金

Analysis and visualization of longitudinal assessments of clinical, functional and psychosocial state of AD patients from the Massachusetts home care program
对马萨诸塞州家庭护理项目 AD 患者的临床、功能和心理社会状态的纵向评估进行分析和可视化
  • 批准号:
    10756631
  • 财政年份:
    2021
  • 资助金额:
    $ 70.15万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC)
  • 批准号:
    10491782
  • 财政年份:
    2021
  • 资助金额:
    $ 70.15万
  • 项目类别:
Facilitating and Supporting Industry Engagement
促进和支持行业参与
  • 批准号:
    10837221
  • 财政年份:
    2021
  • 资助金额:
    $ 70.15万
  • 项目类别:
Al-Supported In-Home Brain Assessments for Older Adults and Persons with Alzheimer's Disease
Al 支持的针对老年人和阿尔茨海默病患者的家庭大脑评估
  • 批准号:
    10755044
  • 财政年份:
    2021
  • 资助金额:
    $ 70.15万
  • 项目类别:
Validating novel sleep sensors and devices in older adults with Alzheimer's disease
在患有阿尔茨海默病的老年人中验证新型睡眠传感器和设备
  • 批准号:
    10756674
  • 财政年份:
    2021
  • 资助金额:
    $ 70.15万
  • 项目类别:
Creation of a technology-ready cohort for patients with Alzheimer's disease and related dementias and their caregivers
为阿尔茨海默病和相关痴呆症患者及其护理人员创建技术就绪队列
  • 批准号:
    10782660
  • 财政年份:
    2021
  • 资助金额:
    $ 70.15万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC)
  • 批准号:
    10675671
  • 财政年份:
    2021
  • 资助金额:
    $ 70.15万
  • 项目类别:
Massachusetts AI and Technology Center for Connected Care in Aging and Alzheimer's Disease (MAITC)
马萨诸塞州老龄化和阿尔茨海默病互联护理人工智能和技术中心 (MAITC)
  • 批准号:
    10274688
  • 财政年份:
    2021
  • 资助金额:
    $ 70.15万
  • 项目类别:
Passive Monitoring of Walking Cadence as a Novel Tool for Aging and Cognitive Health Assessment
步行节奏的被动监测作为衰老和认知健康评估的新工具
  • 批准号:
    10755452
  • 财政年份:
    2021
  • 资助金额:
    $ 70.15万
  • 项目类别:
Leveraging electronic health record tools to reduce health disparities for patients with uncontrolled hypertension
利用电子健康记录工具减少未受控制的高血压患者的健康差异
  • 批准号:
    10542667
  • 财政年份:
    2020
  • 资助金额:
    $ 70.15万
  • 项目类别:

相似海外基金

Islet dosing and loading density in injection molded macroencapsulation devices
注塑宏观封装装置中的胰岛剂量和装载密度
  • 批准号:
    10716174
  • 财政年份:
    2023
  • 资助金额:
    $ 70.15万
  • 项目类别:
Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy
大麻二酚/棕榈酰乙醇酰胺舌下片用于治疗疼痛性糖尿病周围神经病变
  • 批准号:
    10761403
  • 财政年份:
    2023
  • 资助金额:
    $ 70.15万
  • 项目类别:
Depleting autoantibodies for the treatment of autoimmunity
消耗自身抗体来治疗自身免疫
  • 批准号:
    10698700
  • 财政年份:
    2022
  • 资助金额:
    $ 70.15万
  • 项目类别:
Novel approaches to identify and quantify the impact of drug-drug interactions in older adults with diabetes, with a focus on multimorbidity and polypharmacy
识别和量化老年糖尿病患者药物相互作用影响的新方法,重点关注多发病和多药治疗
  • 批准号:
    10599953
  • 财政年份:
    2021
  • 资助金额:
    $ 70.15万
  • 项目类别:
Novel approaches to identify and quantify the impact of drug-drug interactions in older adults with diabetes, with a focus on multimorbidity and polypharmacy
识别和量化老年糖尿病患者药物相互作用影响的新方法,重点关注多发病和多药治疗
  • 批准号:
    10214966
  • 财政年份:
    2021
  • 资助金额:
    $ 70.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了